LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,207,475 | -51.7% | 32,864 | -50.4% | 0.01% | -64.3% |
| Q2 2023 | $4,575,032 | +345.8% | 66,276 | +211.4% | 0.01% | +250.0% |
| Q1 2023 | $1,026,363 | +7.2% | 21,285 | +10.9% | 0.00% | 0.0% |
| Q4 2022 | $957,865 | -48.6% | 19,188 | -58.0% | 0.00% | -55.6% |
| Q3 2022 | $1,864,000 | +42.0% | 45,682 | +91.3% | 0.01% | +28.6% |
| Q2 2022 | $1,313,000 | +22.6% | 23,876 | -19.0% | 0.01% | +40.0% |
| Q1 2022 | $1,071,000 | +31.4% | 29,474 | +68.7% | 0.01% | +150.0% |
| Q4 2021 | $815,000 | – | 17,476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |